Clinical trials query results
From Health Canada
- Medical condition:
- MALIGNANT PLEURAL MESOTHELIOMA
- Medical condition:
- ADULT FEMALE,ADULT MALE
- Drug name:
- RAD-IFN (NADOFARAGENE FIRADENOVEC)/ CELECOXIB/ GEMCITABINE
- Protocol title:
- A PHASE III, OPEN LABEL, RANDOMIZED, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF INTRAPLEURAL ADMINISTRATION OF ADENOVIRUS-DELIVERED INTERFERON ALPHA-2B (RAD-IFN) IN COMBINATION WITH CELECOXIB AND GEMCITABINE IN PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA
- Sponsor name:
- TRIZELL, LTD
- Date of no objection letter:
- 2019-03-07
- Control number:
- 224389
- Trial status:
- ONGOING
- Date study started:
- 2019-12-12